Previous 10 | Next 10 |
Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets to Strengthen Next-Gen CAR Designs PR Newswire BOSTON , April 2, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurit...
2024-03-31 06:26:00 ET 3 Tips for Sizing Your Penny Stocks Positions in 2024 Sizing positions correctly is a cornerstone of successful investing, especially when dealing with penny stocks. The unique nature of penny stocks , with their potential for substantial gains, requires a nua...
2024-03-28 13:46:05 ET More on Invesco S&P 500 Equal Weight ETF: RSP: Equal Weighting The S&P 500 To Minimize Magnificent Seven Exposure Is Not Optimal RSP: I Firmly Believe In An Allocation To Equal-Weight At This Juncture RSP: Happy 2024! Don't Make Decisio...
2024-03-28 09:23:44 ET More on Ginkgo Bioworks Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation ProteoNic partners with Ginkgo Bioworks, joins Ginkgo...
Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins to Control Ice in Extreme Cold Weather Environments PR Newswire BOSTON , March 28, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurit...
AQUA Cultured Foods Partners with Ginkgo Bioworks to Optimize Alt-Seafood Production PR Newswire The partners will work to optimize AQUA Cultured Foods' fermentation technology and advance the development and production of AQUA's 100% fish-free products that emulate the look, ...
Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins PR Newswire Imagindairy and Ginkgo will leverage Ginkgo Protein Expression Services and Imagindairy's process development and scale-up expertise to economically p...
2024-03-15 17:07:00 ET Ginkgo Bioworks (NYSE: DNA) has a lot going for it. It's a favorite of Cathie Wood's Ark Innovation ETF , it's a popular collaborator in the biopharma sector, and its positioning at the intersection of biotechnology, artificial intelligence (AI), and labor...
2024-03-13 07:17:14 ET More on Ginkgo Bioworks Holdings Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks acquires Proof Diagnostics to expand gene editing service offerings Read the full article on Seeking Alp...
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago PR Newswire The TGS program, a leading example of biosecurity infrastructure, operates at a total of nine US locations and leverages voluntary nasal swabs as wel...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Holdings Inc. Class A Company Name:
DNA Stock Symbol:
NYSE Market:
2024-05-20 12:40:00 ET Ginkgo Bioworks (NYSE: DNA) stock has dropped more than 10% since its latest quarterly report showing a more than 53% decline in Q1 revenue and continued net losses from its business. BTIG analyst Mark Massaro downgraded Ginkgo stock to sell, and lowered h...
Ark Investment Management, led by star investor Cathie Wood, is facing a harsh reality in 2024. While the broader market is hit...
2024-05-18 14:38:00 ET Ginkgo Bioworks (NYSE: DNA) is a cell programming company that claims to have large addressable markets (for bioengineered products) in multiple industries in which it can play a key role, and that those are worth trillions of dollars in total. But the pro...